Over 400 New Jersey Auctions End Tomorrow 04/25 - Bid Now
Over 1650 Total Lots Up For Auction at Four Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/06, NJ 05/08

Viz.ai scores 510(k) clearance for Viz ICH Plus for quantifying intracerebral hemorrhages

por John R. Fischer, Senior Reporter | February 16, 2024
Artificial Intelligence CT Stroke X-Ray
Viz ICH Plus (Photo courtesy of Viz.ai)
Viz.ai has obtained 510(k) clearance for its algorithm, Viz ICH Plus, designed to identify, label, and quantify the volume of segmentable brain structures on non-contrast CT scans to diagnose suspected cases of stroke-causing intracerebral hemorrhages.

The software analyzes intracranial hyperdensities, lateral ventricles, and midline shifts to calculate brain bleed volume, and uses this information to help clinicians determine and apply the best treatment to a patient in a timely fashion.

"The ability and mobility to obtain accurate and quantifiable measurements of intracerebral hemorrhages through Viz ICH Plus significantly enhances our decision-making process,” said Dr. Peter Kan, professor, and chair of the department of neurosurgery at the University of Texas Medical Branch, in a statement.
stats
DOTmed text ad

New Fully Configured 80-slice CT in 2 weeks with Software Upgrades for Life

For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.

stats
Viz ICH Plus is available on the company’s AI-powered Viz.ai One enterprise platform, which is used by more than 1,500 providers in the U.S. and made up of multiple care suites, from neuro to trauma, to help multidisciplinary care teams coordinate care and radiology workflow across mobile and desktop systems. Along with Viz ICH, the solution makes up Viz Hemorrhage, which is 38 seconds faster than standard care, alerts providers in less than 30 seconds, and reduces lengths of stay by 35%.

In addition to stroke risks, the company, over the last year, has concentrated largely on the application of its platform in vascular and cardiac care. Last March, it obtained 510(k) clearance for its detection algorithm for abdominal aortic aneurysms, Viz AAA, to tip clinicians to imminent risks of ruptures from CT angiography scans.

It also expanded into outpatient ambulatory centers to accelerate clinical trial recruitment for heart failure using its solution, Viz RECRUIT, to aid with patient identification for these trials.

You Must Be Logged In To Post A Comment